Skip to content

Scholar Rock SRRK Accounts Payable

Accounts Payable at other companies

Biogen logo
BiogenBIIB
$358.5M-8.4%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$7.29M-17.0%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$313.05M-1.5%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$10.78M+53.6%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$7.15M-36.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$13.74M-2.9%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's accounts payable?
Scholar Rock (SRRK) reported accounts payable of $9.22M in Q1 2026.
How has Scholar Rock's accounts payable changed year-over-year?
Scholar Rock's accounts payable increased by 107.8% year-over-year, from $4.44M to $9.22M.
What is the long-term trend for Scholar Rock's accounts payable?
Over 5 years (2020 to 2025), Scholar Rock's accounts payable has grown at a 24.8% compound annual growth rate (CAGR), from $3.41M to $10.3M.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.